Articles that mention Allergan -BoardProspects

Allergan

0 Comments Leave a Comment

1-15 of 37 1 2 3 »
1. Mentioned In 37 Articles
2. Abbvie is Buying Botox-Maker Allergan in a $63 Billion Pharma Mega-Deal
  
  Explore Stock Market Data Today Jun 25 2019 BoardNews
  
  ...Allergan share. The offer represents a 45% premium to the closing price of Allergan's shares on Wednesday... Allergan shareholders will receive 0.8660 AbbVie shares and $120.30 in cash for each Allergan share that they ...
  Read Full Article
  
  Comment
  
  Mentions: Wall Street Allergan CEO
3. Teva CEO Kåre Schultz Nabs Whopping $33M in First Full Year at the Helm
  
  Explore Pharma News Apr 17 2019 BoardBlogs
  
  ...man, who departed after a series of costly missteps, not the least of which was a doomed $40.5 billion buy of Allergan’s generics unit. RELATED: Teva lures Lundbeck chief Schultz with $52M package that makes him among ph...
  Read Full Article
  
  Comment
  
  Mentions: Allergan CEO
4. Allergan (AGN) Says Proxy Advisory Firms ISS and Glass Lewis Support All its Board's Voting ...
  
  Explore StreetInsider.com Apr 15 2019 BoardNews
  
  Commenting on the ISS and Glass Lewis reports, Allergans Board of Directors said: We are pleased with the support we have received from both ...
  Read Full Article
  
  Comment
  
  Mentions: Proxy Advisory ISS Allergan
5. Here’s One Way to Tell if a Company is Overpaying its CEO
  
  Explore MarketWatch Apr 14 2019 BoardBlogs
  
  ...s. In 2014-15, for example, about 28%, or $16.5 million, of overall CEO pay of $58 million at the botox maker Allergan Inc. AGN, -0.06% was granted for meeting non-GAAP earnings targets — the company had a net loss in th...
  Read Full Article
  
  Comment
  
  Mentions: Management SEC crisis
6. AbbVie Investors Agitate for Chair-CEO Split, Flagging Bonus Pay and Humira Hikes
  
  Explore Pharma News Apr 2 2019 BoardNews
  
  ...ble pricing of Humira,” Magaziner said. The call for an AbbVie leadership shakeup comes amid a proxy fight at Allergan that began when activist investor Appaloosa demanded a chairman-CEO split. The hedge fund has taken s...
  Read Full Article
  
  Comment
  
  Mentions: Investors SEC Mylan
7. Hedge Fund Appaloosa Unimpressed by Allergan Board Promises
  
  Explore Channel NewsAsia Mar 25 2019 BoardNews
  
  ... Allergan since last year to separate the roles of CEO and chairman or potentially sell or merge the company. Allergan on Friday agreed to split its chairman and chief executive roles, but only at its next scheduled lead...
  Read Full Article
  
  Comment
  
  Mentions: Allergan Appaloosa
8. Starboard vs. Bristol-Myers Squibb: Who'll Win This Brewing Battle?
  
  Explore Fool.com Mar 20 2019 BoardBlogs
  
  ...rd, and Starboard pointed to the $66 billion merger between Actavis and Allergan. To make a long story short, Allergan shares have lost 50% of their value since the deal closed four years ago. Rather than take a huge ris...
  Read Full Article
  
  Comment
  
  Mentions: Management Investors acquisition
9. Allergan Shareholder Chevedden Backs Appaloosa's Proposal to Split CEO-Chairman Role
  
  Explore Yahoo! Finance Feb 28 2019 BoardNews
  
  ...e" to Allergan's operations and on Thursday redirected Reuters to its earlier response when asked to comment. Allergan's shares, which fell 18.3 pct in 2018, have been lagging those of its peers on account of dropped pla...
  Read Full Article
  
  Comment
  
  Mentions: Conference Investment Management
10. Robert J. Hugin Appointed to Allergan Board of Directors
  
  Explore PR Newswire Feb 20 2019 BoardMoves
  
  ...SE:AGN), a leading global biopharmaceutical company, today announced thatRobert J. Huginhas been appointed to Allergan's Board of Directors, effective immediately. Mr. Hugin was formerly the Chief Executive Officer and C...
  Read Full Article
  
  Comment
  
  Mentions: NYSE Celgene Corporation Allergan
11. Appaloosa Sends Letter to Allergan Board of Directors in Response to Latest Failed Corporate ...
  
  Explore businesswire.com Feb 19 2019 BoardNews
  
  ...iver & Jacobson IMPORTANT NOTICE Funds advised by Appaloosa LP (“Appaloosa”) have submitted to Allergan plc (“Allergan”) a shareholder proposal to separate the roles of Chairman and Chief Executive Officer to be consider...
  Read Full Article
  
  Comment
  
  Mentions: NYSE Allergan Canada
12. David Tepper’s Appaloosa Hedge Fund just Slammed the Leadership of $50 Billion Drugmaker Allergan, and is Calling for Change
  
  Explore Business Insider Feb 5 2019 BoardNews
  
  ...sday. Appaloosa wants Allergan's board to separate the role of chairman and CEO, which today are both held by Allergan's Brent Saunders. In a Tuesday letter, Appaloosa slammed Allergan's executive decision-making, "the r...
  Read Full Article
  
  Comment
  
  Mentions: Leadership Leadership Structure Hedge Fund
13. A Handful of Allergan's Top Shareholders Want to Bring Back the Old CEO as Chairman
  
  Explore Business Insider Jun 7 2018 BoardNews
  
  ...est Allergan holders. A spokeswoman for Allergan declined to comment. Pyott, who served as chief executive of Allergan from 1998 to 2015, declined to comment when Business Insider asked him if he was interested in a new ...
  Read Full Article
  
  Comment
  
  Mentions: Investment Management Investors
14. Allergan Responds to Public Shareholder Letter
  
  Explore Stock Market Jun 5 2018 BoardNews
  
  ..., including but not limited to Allergan's Annual Report on Form 10-K for the year ended December 31, 2017 and Allergan's Quarterly Report on Form 10-Q for the period ended March 31, 2018. Except as expressly required by ...
  Read Full Article
  
  Comment
  
  Mentions: National Association of Corporate Directors Management NYSE
15. Hedge Fund Appaloosa Asks Allergan to Split Chairman-CEO Position
  
  Explore reuters.com Jun 5 2018 BoardNews
  
  ...ionaire investor David Tepper’s hedge fund Appaloosa Management and Senator Investment Group on Tuesday asked Allergan Plc’s (AGN.N) board to split the office of the chief executive officer and chairman. In May, Appaloos...
  Read Full Article
  
  Comment
  
  Mentions: Investment Management Hedge Fund
16. Now that Ironwood's Spinning off R&D, Activist Alex Denner is Easing Up
  
  Explore Pharma News Jun 1 2018 BoardNews
  
  ...hang onto its treatments for GI diseases, gout and abdominal pain—including Linzess, a product it shares with Allergan—as well as a candidate for gastroesophageal reflux disease. The new company’s pipeline, meanwhile, wi...
  Read Full Article
  
  Comment
  
  Mentions: Credit Suisse Sarissa Allergan
17. 1-15 of 37 1 2 3 »